The Citizens Commission on Human Rights International (CCHR) has relaunched its documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" in response to ongoing acts of violence associated with psychiatric drugs and intensifying professional debates over prescribing practices. The organization is also drawing attention to Tennessee's pioneering law requiring toxicology screening for psychotropic drugs in cases of mass violence, alongside its White Paper documenting 145 incidents in which perpetrators were taking or withdrawing from these drugs.
The two-hour documentary compiles evidence from court records, regulatory warnings, expert testimony, and survivor accounts linking antidepressants, antipsychotics, benzodiazepines, mood stabilizers, and stimulants to aggression, akathisia, suicidal ideation, and homicidal behavior. Manufacturer labels themselves list risks including mania, hostility, psychosis, and homicidal ideation. Global drug regulators have issued more than 100 warnings citing violent or suicidal effects. Yet these risks remain under-examined in both clinical practice and violence investigations.
CCHR's White Paper details 145 documented cases of shootings, stabbings, vehicle assaults, strangulations, and other attacks committed by individuals on or withdrawing from psychiatric drugs. These incidents resulted in 720 deaths and 1,602 injuries. Approximately 81% occurred in the United States and include dozens of school-related attacks. In only a small fraction of cases were psychotropic drug levels publicly reported in toxicology findings—highlighting a critical data gap that allows potential drug contributions to remain invisible.
Tennessee has taken a concrete step to close that gap. Legislation effective July 1, 2025, mandates testing for psychotropic drugs, including at therapeutic levels, in autopsies of individuals suspected of mass shootings resulting in four or more deaths. A 2026 expansion extends provisions to incidents involving four or more injuries or attempted mass killings and allows testing of living suspects with consent. Results are studied by the University of Tennessee Health Science Center and reported to the state legislature. CCHR urges other states and federal authorities to adopt similar requirements so that patterns of drug-related violence can be identified and addressed.
These developments occur against a backdrop of growing debate within and beyond the mental health professions. Clinicians, researchers, and patient advocates increasingly question polypharmacy—the simultaneous prescription of multiple mind-altering drugs—and the frequent absence of thorough physical examinations and laboratory testing before and during treatment. Withdrawal reactions from antidepressants, antipsychotics, and benzodiazepines can emerge within hours or days and may include agitation, impulsivity, and suicidal or aggressive ideation. Roger McFillin, Ph.D., a clinical psychologist, recently commented on the practice of polypharmacy as the standard of care in psychiatry, referring to a case where a young mother progressively worsened with multiple prescriptions of psychotropic drugs, with tragic results. He stated: "That is not a scandal within psychiatry. That is psychiatry."
Critics argue that adverse effects are too often misattributed to the patient's underlying condition rather than the drugs themselves, leading to dose escalations or additional medications that compound the problem.
Historical precedents reinforce the need for accountability. Courts in several countries have held physicians criminally responsible when reckless prescribing or lack of treatment oversight contributed to fatal outcomes. Such cases underscore a core principle: when powerful chemicals that alter mood, cognition, and perception are administered without adequate monitoring or recognition of known risks, preventable harm can result.
CCHR International President Jan Eastgate stated: "The public record of regulatory warnings, clinical case reports, and documented acts of violence can no longer be sidelined. When drugs capable of inducing aggression and homicidal ideation are prescribed in unstudied combinations and escalating doses, the outcomes can be catastrophic. Tennessee's toxicology requirement creates a factual baseline that is essential for both prevention and accountability. The debates now underway among mental health professionals about polypharmacy and informed consent must treat these risks as central, not secondary."
Prescription for Violence is available for viewing through the CCHR website and mobile app. CCHR, which was established in 1969 by the Church of Scientology and New York-based professor of psychiatry, Thomas Szasz, emphasizes that no one should discontinue prescribed psychotropic drugs without medical supervision. The organization continues to call for legislative hearings, mandatory toxicology protocols in violence investigations, and full disclosure of drug risks.
